Madrigal Pharmaceuticals, Inc. is a company in the U.S. stock market and it is a holding in 34 U.S.-traded ETFs. MDGL has around 908.6K shares in the U.S. ETF market. The largest ETF holder of MDGL is the SPDR S&P Biotech ETF (XBI), with approximately 337.57K shares. Investors may also find of interest that the ETF with the largest allocation to MDGL stock is ALPS Medical Breakthroughs ETF (SBIO), with a portfolio weight of 1.71%. On average, U.S. ETFs allocate 0.26% of MDGL to their portfolios.
Additionally, MDGL is a favorite stock for Vanilla and Equal ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with MDGL as a holding is the ALPS Medical Breakthroughs ETF (SBIO), with a return of 19.89%.